US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% NVDA $233.95 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% JNJ $256.03 ▲+0.00% SPCX $158.96 ▲+0.00%
FinancialContent

Articles published by Clover Biopharmaceuticals

News headline image
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Provides Updates on Business and R&D Pipeline Development
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Announces Corporate Updates and Full Year 2022 Financial Results
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
UPDATE -- Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
From Clover Biopharmaceuticals
Via GlobeNewswire
Tickers DVAX
News headline image
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
From Clover Biopharmaceuticals
Via GlobeNewswire
Tickers DVAX
News headline image
Clover Provides Update on 2022 Corporate Milestones
From Clover Biopharmaceuticals
Via GlobeNewswire
Tickers DVAX